1. Home
  2. OVID vs SRBK Comparison

OVID vs SRBK Comparison

Compare OVID & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • SRBK
  • Stock Information
  • Founded
  • OVID 2014
  • SRBK 1887
  • Country
  • OVID United States
  • SRBK United States
  • Employees
  • OVID N/A
  • SRBK N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • SRBK
  • Sector
  • OVID Health Care
  • SRBK
  • Exchange
  • OVID Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • OVID 85.2M
  • SRBK 95.0M
  • IPO Year
  • OVID 2017
  • SRBK N/A
  • Fundamental
  • Price
  • OVID $1.06
  • SRBK $11.08
  • Analyst Decision
  • OVID Strong Buy
  • SRBK
  • Analyst Count
  • OVID 5
  • SRBK 0
  • Target Price
  • OVID $4.04
  • SRBK N/A
  • AVG Volume (30 Days)
  • OVID 216.9K
  • SRBK 27.1K
  • Earning Date
  • OVID 11-12-2024
  • SRBK 01-01-0001
  • Dividend Yield
  • OVID N/A
  • SRBK N/A
  • EPS Growth
  • OVID N/A
  • SRBK N/A
  • EPS
  • OVID N/A
  • SRBK 0.11
  • Revenue
  • OVID $631,695.00
  • SRBK $30,867,000.00
  • Revenue This Year
  • OVID $21.51
  • SRBK N/A
  • Revenue Next Year
  • OVID $7,300.79
  • SRBK N/A
  • P/E Ratio
  • OVID N/A
  • SRBK $96.53
  • Revenue Growth
  • OVID 113.21
  • SRBK 164.18
  • 52 Week Low
  • OVID $0.68
  • SRBK $8.94
  • 52 Week High
  • OVID $4.10
  • SRBK $11.28
  • Technical
  • Relative Strength Index (RSI)
  • OVID 37.15
  • SRBK 53.21
  • Support Level
  • OVID $1.11
  • SRBK $10.84
  • Resistance Level
  • OVID $1.47
  • SRBK $11.28
  • Average True Range (ATR)
  • OVID 0.11
  • SRBK 0.19
  • MACD
  • OVID -0.02
  • SRBK -0.00
  • Stochastic Oscillator
  • OVID 6.82
  • SRBK 72.97

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: